Conversely, triple-negative breast cancer (TNBC) is characterized by a lack of ERs, PRs, and HER2, and is generally associated with a more aggressive clinical course and resistance to standard hormonal therapies and HER2-targeted interventions [21]. Here, ERBB2 is linked to triple-negative breast carcinoma.